NantHealth announced that the company has implemented a reverse stock split at a ratio of 1-for-15, which is expected to be effective 5 p.m. Eastern Time on December 15. The company’s common stock is expected to begin trading on a split-adjusted basis at commencement of trading on Friday, December 16. The reverse stock split was approved by NantHealth’s stockholders on August 18 and is intended to increase the per share trading price of the company’s common stock, which the company expects will satisfy the minimum bid price requirement for continued listing on the Nasdaq Global Select Market.
Published first on TheFly
